Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy

NCT05243823 · clinicaltrials.gov ↗

COMPLETED

Status

500000

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Vaginal Atrophy

Interventions

DRUG: Vagifem®
DRUG: Non-Vagifem® LDVE, Estradiol

Sponsor

Novo Nordisk A/S